Salbutamol Completed Phase 1 Trials for Chronic Asthma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00739297The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)